Ebola Virus and Marburg Virus in Human Milk Are Inactivated by Holder Pasteurization

Erin Hamilton Spence, Monica Huff, Karen Shattuck, Amy Vickers, Nadezda Yun, Slobodan Paessler

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Potential donors of human milk are screened for Ebola virus (EBOV) using standard questions, but testing for EBOV and Marburg virus (MARV) is not part of routine serological testing performed by milk banks. Research aim: This study tested the hypothesis that EBOV would be inactivated in donor human milk (DHM) by standard pasteurization techniques (Holder) used in all North American nonprofit milk banks. Methods: Milk samples were obtained from a nonprofit milk bank. They were inoculated with EBOV (Zaire strain) and MARV (Angola strain) and processed by standard Holder pasteurization technique. Plaque assays for EBOV and MARV were performed to detect the presence of virus after pasteurization. Results: Neither EBOV nor MARV was detectable by viral plaque assay in DHM or culture media samples, which were pasteurized by the Holder process. Conclusion: EBOV and MARV are safely inactivated in human milk by standard Holder pasteurization technique. Screening for EBOV or MARV beyond questionnaire and self-deferral is not needed to ensure safety of DHM for high-risk infants.

Original languageEnglish (US)
Pages (from-to)351-354
Number of pages4
JournalJournal of Human Lactation
Volume33
Issue number2
DOIs
StatePublished - May 1 2017

Fingerprint

Marburgvirus
Ebolavirus
Pasteurization
Human Milk
Milk Banks
Tissue Donors
Viral Plaque Assay
Angola
Culture Media
Milk
Viruses
Safety

Keywords

  • American Academy of Pediatrics
  • breastfeeding
  • Human Milk Banking Association of America
  • human milk substitute
  • infant nutrition
  • milk banking

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Ebola Virus and Marburg Virus in Human Milk Are Inactivated by Holder Pasteurization. / Hamilton Spence, Erin; Huff, Monica; Shattuck, Karen; Vickers, Amy; Yun, Nadezda; Paessler, Slobodan.

In: Journal of Human Lactation, Vol. 33, No. 2, 01.05.2017, p. 351-354.

Research output: Contribution to journalArticle

@article{ef0e261a638e4e29b25ee4f4cdc1d433,
title = "Ebola Virus and Marburg Virus in Human Milk Are Inactivated by Holder Pasteurization",
abstract = "Background: Potential donors of human milk are screened for Ebola virus (EBOV) using standard questions, but testing for EBOV and Marburg virus (MARV) is not part of routine serological testing performed by milk banks. Research aim: This study tested the hypothesis that EBOV would be inactivated in donor human milk (DHM) by standard pasteurization techniques (Holder) used in all North American nonprofit milk banks. Methods: Milk samples were obtained from a nonprofit milk bank. They were inoculated with EBOV (Zaire strain) and MARV (Angola strain) and processed by standard Holder pasteurization technique. Plaque assays for EBOV and MARV were performed to detect the presence of virus after pasteurization. Results: Neither EBOV nor MARV was detectable by viral plaque assay in DHM or culture media samples, which were pasteurized by the Holder process. Conclusion: EBOV and MARV are safely inactivated in human milk by standard Holder pasteurization technique. Screening for EBOV or MARV beyond questionnaire and self-deferral is not needed to ensure safety of DHM for high-risk infants.",
keywords = "American Academy of Pediatrics, breastfeeding, Human Milk Banking Association of America, human milk substitute, infant nutrition, milk banking",
author = "{Hamilton Spence}, Erin and Monica Huff and Karen Shattuck and Amy Vickers and Nadezda Yun and Slobodan Paessler",
year = "2017",
month = "5",
day = "1",
doi = "10.1177/0890334416685564",
language = "English (US)",
volume = "33",
pages = "351--354",
journal = "Journal of Human Lactation",
issn = "0890-3344",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Ebola Virus and Marburg Virus in Human Milk Are Inactivated by Holder Pasteurization

AU - Hamilton Spence, Erin

AU - Huff, Monica

AU - Shattuck, Karen

AU - Vickers, Amy

AU - Yun, Nadezda

AU - Paessler, Slobodan

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Background: Potential donors of human milk are screened for Ebola virus (EBOV) using standard questions, but testing for EBOV and Marburg virus (MARV) is not part of routine serological testing performed by milk banks. Research aim: This study tested the hypothesis that EBOV would be inactivated in donor human milk (DHM) by standard pasteurization techniques (Holder) used in all North American nonprofit milk banks. Methods: Milk samples were obtained from a nonprofit milk bank. They were inoculated with EBOV (Zaire strain) and MARV (Angola strain) and processed by standard Holder pasteurization technique. Plaque assays for EBOV and MARV were performed to detect the presence of virus after pasteurization. Results: Neither EBOV nor MARV was detectable by viral plaque assay in DHM or culture media samples, which were pasteurized by the Holder process. Conclusion: EBOV and MARV are safely inactivated in human milk by standard Holder pasteurization technique. Screening for EBOV or MARV beyond questionnaire and self-deferral is not needed to ensure safety of DHM for high-risk infants.

AB - Background: Potential donors of human milk are screened for Ebola virus (EBOV) using standard questions, but testing for EBOV and Marburg virus (MARV) is not part of routine serological testing performed by milk banks. Research aim: This study tested the hypothesis that EBOV would be inactivated in donor human milk (DHM) by standard pasteurization techniques (Holder) used in all North American nonprofit milk banks. Methods: Milk samples were obtained from a nonprofit milk bank. They were inoculated with EBOV (Zaire strain) and MARV (Angola strain) and processed by standard Holder pasteurization technique. Plaque assays for EBOV and MARV were performed to detect the presence of virus after pasteurization. Results: Neither EBOV nor MARV was detectable by viral plaque assay in DHM or culture media samples, which were pasteurized by the Holder process. Conclusion: EBOV and MARV are safely inactivated in human milk by standard Holder pasteurization technique. Screening for EBOV or MARV beyond questionnaire and self-deferral is not needed to ensure safety of DHM for high-risk infants.

KW - American Academy of Pediatrics

KW - breastfeeding

KW - Human Milk Banking Association of America

KW - human milk substitute

KW - infant nutrition

KW - milk banking

UR - http://www.scopus.com/inward/record.url?scp=85018283780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018283780&partnerID=8YFLogxK

U2 - 10.1177/0890334416685564

DO - 10.1177/0890334416685564

M3 - Article

C2 - 28135118

AN - SCOPUS:85018283780

VL - 33

SP - 351

EP - 354

JO - Journal of Human Lactation

JF - Journal of Human Lactation

SN - 0890-3344

IS - 2

ER -